Copyright
©The Author(s) 2021.
World J Diabetes. Jun 15, 2021; 12(6): 883-892
Published online Jun 15, 2021. doi: 10.4239/wjd.v12.i6.883
Published online Jun 15, 2021. doi: 10.4239/wjd.v12.i6.883
Table 1 Characteristics of include participants (n = 424)
| Characteristic | Value |
| Age (median years, IQR) | 69 (63-76) |
| Gender (male, %) | 311 (73.3) |
| Aboriginal or Torres strait islander, n (%) | 19 (4.5) |
| Presenting problem, n (%) | |
| Carotid artery disease | 63 (14.9) |
| Aortic or peripheral aneurysm | 121 (28.5) |
| Lower limb ischemia | 240 (56.6) |
| Smoking status, n (%) | |
| Current | 101 (23.8) |
| Former | 211 (49.8) |
| Never | 111 (26.2) |
| Missing | 1 (0.2) |
| Medications, n (%) | |
| Aspirin | 278 (65.6) |
| Other anti-platelet | 84 (19.8) |
| Statins | 324 (76.4) |
| Metformin | 251 (59.2) |
| Other oral hypoglycemics | 154 (36.3) |
| Insulin | 98 (23.1) |
| Co-morbidities, n (%) | |
| Ischemic heart disease (IHD) | 201 (47.4) |
| Stroke | 47 (11.1) |
| Vitals (median, IQR) | |
| Glycated hemoglobin (HbA1c) (%) | 6.9 (6.2-7.8) |
| Low-density lipoprotein (LDL)-c (mmol/L) | 2 (1.5-2.6) |
| Systolic blood pressure (mmHg) | 139 (125-151) |
| C-reactive protein (mg/L)1 | 2.7 (1.0-6.0) |
- Citation: Golledge J, Drovandi A, Rowbotham S, Velu R, Quigley F, Jenkins J. Control of modifiable risk factors and major adverse cardiovascular events in people with peripheral artery disease and diabetes. World J Diabetes 2021; 12(6): 883-892
- URL: https://www.wjgnet.com/1948-9358/full/v12/i6/883.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i6.883